E3 ubiquitin ligase ITCH-mediated proteasomal degradation of WBP2 sensitizes breast cancer cells to chemotherapy through restraining AMOTL2/c-JUN axis

This publication has 50 references indexed in Scilit:

• Induced expression of AMOT reverses adriamycin resistance in breast cancer cells
  Cell Biology International, 2024
• Potential role of CXCR4 in trastuzumab resistance in breast cancer patients
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
• WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple‐negative breast cancer via NF‐κB activation
  Molecular Oncology, 2021
• Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome
  The American Journal of Surgery, 2021
• Itch attenuates CD4 T‐cell proliferation in mice by limiting WBP2 protein stability
  European Journal of Immunology, 2020
• Regulation of autoimmune disease by the E3 ubiquitin ligase Itch
  Cellular Immunology, 2019
• ASPP2 suppresses invasion and TGF-β1-induced epithelial–mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer
  Cancer Letters, 2017
• WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206
  Cancer Chemotherapy and Pharmacology, 2017
• The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
  Cancer Cell, 2008
• The Nedd4-like family of E3 ubiquitin ligases and cancer
  Cancer and Metastasis Reviews, 2007